| Literature DB >> 33319484 |
Sara Leal-Marin1, Thomas Kern2, Nicola Hofmann3, Olena Pogozhykh4, Carsten Framme2, Martin Börgel3, Constanca Figueiredo4, Birgit Glasmacher1, Oleksandr Gryshkov1.
Abstract
Human amniotic membrane (hAM) has been employed as scaffolding material in a wide range of tissue engineering applications, especially as a skin dressing and as a graft for corneal treatment, due to the structure of the extracellular matrix and excellent biological properties that enhance both wound healing and tissue regeneration. This review highlights recent work and current knowledge on the application of native hAM, and/or production of hAM-based tissue-engineered products to create scaffolds mimicking the structure of the native membrane to enhance the hAM performance. Moreover, an overview is presented on the available (cryo) preservation techniques for storage of native hAM and tissue-engineered products that are necessary to maintain biological functions such as angiogenesis, anti-inflammation, antifibrotic and antibacterial activity.Entities:
Keywords: cryopreservation; cryoprotective agent (CPA); extracellular matrix (ECM); human amniotic membrane (hAM); scaffold; tissue engineering (TE)
Mesh:
Substances:
Year: 2020 PMID: 33319484 DOI: 10.1002/jbm.b.34782
Source DB: PubMed Journal: J Biomed Mater Res B Appl Biomater ISSN: 1552-4973 Impact factor: 3.368